Literature DB >> 35484367

Integrating Management of Hepatitis C Infection into Primary Care: the Key to Hepatitis C Elimination Efforts.

Allison E Wang1, Eric Hsieh1, Barbara J Turner1, Norah Terrault2,3.   

Abstract

Elimination of hepatitis C virus (HCV), a leading cause of liver disease in the USA and globally, has been made possible with the advent of highly efficacious direct acting antivirals (DAAs). DAA regimens offer cure of HCV with 8-12 weeks of a well-tolerated once daily therapy. With increasingly straightforward diagnostic and treatment algorithms, HCV infection can be managed not only by specialists, but also by primary care providers. Engaging primary care providers greatly increases capacity to diagnose and treat chronic HCV and ultimately make HCV elimination a reality. However, barriers remain at each step in the HCV cascade of care from screening to evaluation and treatment. Since primary care is at the forefront of patient contact, it represents the ideal place to concentrate efforts to identify barriers and implement solutions to achieve universal HCV screening and increase curative treatment.
© 2022. The Author(s), under exclusive licence to Society of General Internal Medicine.

Entities:  

Keywords:  barriers; cascade of care; direct-acting antivirals; screening

Mesh:

Substances:

Year:  2022        PMID: 35484367      PMCID: PMC9551010          DOI: 10.1007/s11606-022-07628-9

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   6.473


  105 in total

1.  Outcomes of treatment for hepatitis C virus infection by primary care providers.

Authors:  Sanjeev Arora; Karla Thornton; Glen Murata; Paulina Deming; Summers Kalishman; Denise Dion; Brooke Parish; Thomas Burke; Wesley Pak; Jeffrey Dunkelberg; Martin Kistin; John Brown; Steven Jenkusky; Miriam Komaromy; Clifford Qualls
Journal:  N Engl J Med       Date:  2011-06-01       Impact factor: 91.245

Review 2.  Drug-Drug Interactions Potential of Direct-Acting Antivirals for the treatment of Chronic Hepatitis C Virus infection.

Authors:  Nadège Néant; Caroline Solas
Journal:  Int J Antimicrob Agents       Date:  2018-10-27       Impact factor: 5.283

3.  Screening for Hepatitis B Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement.

Authors:  Alex H Krist; Karina W Davidson; Carol M Mangione; Michael J Barry; Michael Cabana; Aaron B Caughey; Katrina Donahue; Chyke A Doubeni; John W Epling; Martha Kubik; Gbenga Ogedegbe; Douglas K Owens; Lori Pbert; Michael Silverstein; Melissa A Simon; Chien-Wen Tseng; John B Wong
Journal:  JAMA       Date:  2020-12-15       Impact factor: 56.272

4.  Mapping the Barriers and Facilitators of HCV Treatment Initiation in Methadone Maintenance Therapy Patients: Implications for Intervention Development.

Authors:  Sarah Bauerle Bass; Amy Jessop; Laurie Maurer; Muhamed Gashat; Mohammed Al Hajji; Mercedes Gutierrez
Journal:  J Health Commun       Date:  2017-12-18

Review 5.  Comparison of diagnostic accuracy of aspartate aminotransferase to platelet ratio index and fibrosis-4 index for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: a systemic review and meta-analysis.

Authors:  Guangqin Xiao; Jiayin Yang; Lunan Yan
Journal:  Hepatology       Date:  2014-11-24       Impact factor: 17.425

Review 6.  Diagnosis and Management of Hepatitis C Infection in Primary Care Settings.

Authors:  Debra Guss; Jagannath Sherigar; Paul Rosen; Smruti R Mohanty
Journal:  J Gen Intern Med       Date:  2018-01-19       Impact factor: 5.128

7.  A systematic model improves hepatitis C virus birth cohort screening in hospital-based primary care.

Authors:  A Goel; J Sanchez; L Paulino; C Feuille; J Arend; B Shah; D Dieterich; P V Perumalswami
Journal:  J Viral Hepat       Date:  2017-01-23       Impact factor: 3.728

Review 8.  Hepatitis C virus molecular evolution: transmission, disease progression and antiviral therapy.

Authors:  Maria Victoria Preciado; Pamela Valva; Alejandro Escobar-Gutierrez; Paula Rahal; Karina Ruiz-Tovar; Lilian Yamasaki; Carlos Vazquez-Chacon; Armando Martinez-Guarneros; Juan Carlos Carpio-Pedroza; Salvador Fonseca-Coronado; Mayra Cruz-Rivera
Journal:  World J Gastroenterol       Date:  2014-11-21       Impact factor: 5.742

9.  Doubling Hepatitis C Virus Screening in Primary Care Using Advanced Electronic Health Record Tools-A Non-Randomized Controlled Trial.

Authors:  Leila Hojat; Ann Avery; Peter J Greco; David C Kaelber
Journal:  J Gen Intern Med       Date:  2019-12-02       Impact factor: 5.128

Review 10.  Status of Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection and Remaining Challenges.

Authors:  Thomas F Baumert; Thomas Berg; Joseph K Lim; David R Nelson
Journal:  Gastroenterology       Date:  2018-10-17       Impact factor: 33.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.